| Univariate |  | Multivariate |  |
---|---|---|---|---|
Variables | Odds ratio (95% CI) | P-value* | Odds ratio (95% CI) | P-value^ |
Painful TMDs | Â | Â | Â | Â |
Pandemic | Â | Â | Â | Â |
Before Covid | Reference | - | Reference | - |
During Covid | 0.84 (0.57–1.21) | 0.345 | - | - |
Gender | Â | Â | Â | Â |
Male | Reference | - | Reference | - |
Female | 1.39 (0.86–2.25) | 0.184 | - | - |
Age | 1.05 (1.04–1.07) | < 0.001 | 1.05 (1.03–1.07) | < 0.001 |
Total-DASS | 1.01 (1.00-1.02) | 0.002 | 0.99 (0.98-1.00) | 0.071 |
Total-PSQI | 1.08 (1.02–1.14) | 0.006 | - | - |
Total-OHIP | 1.05 (1.04–1.06) | < 0.001 | 1.05 (1.04–1.07) | < 0.001 |
Non-painful TMDs | Â | Â | Â | Â |
Pandemic | Â | Â | Â | Â |
Before Covid | Reference | - | Reference | - |
During Covid | 1.20 (0.82–1.74) | 0.345 | - | - |
Gender | Â | Â | Â | Â |
Male | Reference | - | Reference | - |
Female | 0.72 (0.45–1.17) | 0.184 | - | - |
Age | 0.95 (0.93–0.97) | < 0.001 | 0.96 (0.94–0.97) | < 0.001 |
Total-DASS | 0.99 (0.98-1.00) | 0.002 | 1.01 (1.00-1.02) | 0.071 |
Total-PSQI | 0.93 (0.88–0.98) | 0.006 | - | - |
Total-OHIP | 0.96 (0.94–0.97) | < 0.001 | 0.95 (0.94–0.96) | < 0.001 |